Contraindications: Lidocaine Injection is contraindicated in patients with a known hypersensitivity to lidocaine or any component of the formulation
severe or persistent upper abdominal pain should prompt urgent medical assessment [10] [11] Dehydration and acute kidney injury (AKI): gastrointestinal fluid losses can lead to dehydration, which may precipitate AKI, particularly in those with pre-existing renal impairment or those taking nephrotoxic medicines Delayed gastric emptying: this may affect the absorption of orally administered medicines, including contraceptive pills and thyroid replacement therapy [11] Injection site reactions: redness, bruising, or discomfort at the subcutaneous injection site Heart rate changes: increases in resting heart rate have been noted with GLP-1 class agents [14] [15] Hypoglycaemia: particularly if used alongside insulin or sulphonylureas Potential pancreatitis risk: a class concern with GLP-1 receptor agonists
BPC-157's angiogenic effects extend throughout the vascular network, while TB-500 diffuses readily across tissues due to its small size and lack of heparin binding
NICE guidelines for weight management do not include lipotropic injections, instead recommending evidence-based interventions such as dietary modification, physical activity, and approved pharmacological treatments
Its cellular impacts on repair and inflammation pathways hint at potential advantages for endometrial and gut lining healing, which can arise in those with persistent reproductive or digestive issues that impact fertility